JUN 19, 2018 6:07 AM PDT

Three-Dimensional Diagnosis of Osteoarthritis

WRITTEN BY: Kara Marker

There is a new way to diagnose arthritis and watch its progression slowly over time to determine the best route of treatment. From the University of Cambridge, scientists introduce an algorithm based on three-dimensional imaging scans to monitor arthritis.

Micrograph showing degenerative joint disease compatible with osteoarthritis. Credit: Nephron

Unlike existing methods, the new approach can detect the smallest changes in arthritic joints. This way, scientists and physicians could test new treatments and understand more about how the disease develops. Learning more about arthritis could help experts better define the differences between severe cases and minor cases of arthritis.

Osteoarthritis is a degenerative joint disease, the most common chronic condition of the joints. It develops when the cartilage that cushions joint movement deteriorates, causing stiffness, swelling, and pain. Excess weight, injury, and overuse can increase the risk of osteoarthritis, and it can only be treated with surgery to replace joints with an artificial alternative.

Current diagnostic methods for osteoarthritis include x-ray imaging, scans of which would show a loss of joint cartilage in joints between bones. However, this method requires human interpretation, which can vary, and it can’t effectively keep track of small changes in joint deterioration over time.

"Our ability to detect structural changes to identify disease early, monitor progression and predict treatment response is frustratingly limited by this,” said lead author Dr. Tom Turmezei.

The new technique is called joint space mapping (JSM), and it uses three-dimensional images from a standard computerized tomography (CT) scan. A CT scan produces cross-sectional images of anatomy, uses only low doses of radiation, and can be used by clinicians to diagnose and monitor various health conditions.

CT scan-directed JSM can successfully identify even the smallest changes in the space between the bones of an arthritic joint. Researchers conducted tests on human hip joints to develop an algorithm for diagnosing osteoarthritis with JSM, and they found that the new test is twice as sensitive – possibly more – as x-rays at detecting small structural changes in the joint

"Using this technique, we'll hopefully be able to identify osteoarthritis earlier, and look at potential treatments before it becomes debilitating," Turmezei explained. "It could be used to screen at-risk populations, such as those with known arthritis, previous joint injury, or elite athletes who are at risk of developing arthritis due to the continued strain placed on their joints."

The present study was published in the journal Scientific Reports.

Source: Arthritis Foundation, U.S. Food and Drug Administration, University of Cambridge

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 03, 2020
Cancer
Improving Diagnostics in Breast Cancer
AUG 03, 2020
Improving Diagnostics in Breast Cancer
Diagnostics is one of the essential tools in a physician’s toolkit. A good diagnostic test can identify whether a ...
SEP 07, 2020
Clinical & Molecular DX
Spot the Robodog Measures COVID Patients' Vitals
SEP 07, 2020
Spot the Robodog Measures COVID Patients' Vitals
Hospital staff caring for COVID-19 patients face the greatest risk of exposure to the virus. A new dog-like robot design ...
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
OCT 06, 2020
Clinical & Molecular DX
A Smart Tattoo That Could Save Your Life
OCT 06, 2020
A Smart Tattoo That Could Save Your Life
Color-changing tattoos, powered by nanotechnology, that sense imbalances in your biochemistry providing a visual signal ...
OCT 13, 2020
Clinical & Molecular DX
Test for Diabetes Checks If the Liver Is Responding
OCT 13, 2020
Test for Diabetes Checks If the Liver Is Responding
Glucagon is a hormone that prevents blood glucose levels from dropping too low by stimulating the liver to convert store ...
Loading Comments...